+May 31, 20260How much of HCA revenue comes from medicaid?Based on HCA Healthcare’s most recent full-year SEC filings for 2025, approximately 12.7% of their net patient service revenues come from Medicaid.Because HCA is the largest for-profit hospital operator in the United States, that relatively small percentage translates to a massive dollar amount:Total 2025 Revenue: HCA generated $75.6 billion in revenue in 2025.Medicaid Dollar Amount: At 12.7%, Medicaid accounts for roughly $9.6 billion of their annual top-line revenue.The Full Payor MixHCA breaks its government payer mix down into traditional fee-for-service and managed care. Here is how their patient revenue is distributed according to their 2025 10-K filing:Payor SourcePercentage of Patient RevenueCommercial / Managed Care~48.0%Medicare (Traditional + Managed)32.7% (14.9% Traditional, 17.8% Managed)Medicaid (Traditional + Managed)12.7% (7.8% Traditional, 4.9% Managed)Other (Self-pay, International, etc.)~6.6%Key Insight: HCA’s overall Medicaid exposure (12.7%) is slightly lower than Universal Health Services (15%). This is primarily because HCA focuses heavily on acute care and high-margin surgical centers in economically growing suburban markets, whereas UHS has a massive behavioral health division, which inherently relies more on Medicaid.However, even at 12.7%, Medicaid is critical to HCA's profitability. In their recent 2025 and early 2026 earnings calls, HCA executives specifically highlighted hundreds of millions of dollars in adjusted earnings driven directly by finalized Medicaid state supplemental payment programs—particularly in massive markets like Texas and Florida. Because these supplemental payments often drop straight to the bottom line, the new federal caps on State Directed Payments are still a major headwind for the company.
+May 28, 20260why hca has so much debt?HCA's debt story is one of the most interesting capital structure case studies in American corporate history. The debt is not a mistake or a sign of financial distress — it is a deliberate, rational, and sustained strategic choice that has created enormous shareholder wealth. Let me explain why from the ground up. The Three Origins of HCA's Debt HCA's ~$45 billion in debt comes from three distinct, overlapping sources that have compounded over time. Origin 1: The 2006 KKR/Bain LBO — The Original Sin Everything starts here. In 2006, KKR, Bain Capital, Merrill Lynch and the Frist family took HCA private in a $33 billion leveraged buyout — the largest in history at the time — loading the company with approximately $28 billion in debt. sec When HCA re-IPO'd in 2011, it did not pay down that LBO debt — it came back to the public markets already deeply leveraged. The PE firms extracted their returns through the IPO and subsequent share sales, but the debt remained on HCA's balance sheet. This is the permanent baseline of HCA's debt load. Every refinancing since has essentially rolled this debt forward at successively lower interest rates, never meaningfully reducing the principal. This is a critical distinction from, say, CHS — whose debt came from an operationally disastrous acquisition. HCA's foundational debt came from a PE transaction on a healthy business, and the business was strong enough to service it comfortably from day one. Origin 2: Aggressive Share Buybacks Funded by Debt — The Ongoing Machine This is the engine that keeps the debt elevated even as the business generates enormous cash flow, and it is entirely intentional. The logic is a form of financial engineering that works beautifully when executed on a high-quality, stable-cash-flow business: HCA generates ~$7–8 billion in free cash flow per year Rather than using that cash to pay down debt, it borrows more and buys back its own shares Fewer shares outstanding means each remaining share is worth more — EPS grows even if net income is flat The interest rate on HCA's debt (~4–5%) is far cheaper than the implied earnings yield on its stock (~8–10%), making debt-financed buybacks mathematically accretive The scale of this is staggering. HCA bought back 26.7 million shares in 2025 alone and authorized a new $10 billion repurchase program. In 2022, the company bought back $7 billion or 30 million shares in a single year. Since the 2011 IPO, HCA has bought back well over $40 billion of its own stock — nearly the entire current market cap. This buyback activity is financed partly by cash flow and partly by issuing new debt, keeping total debt elevated even as the business grows. sec The result of this relentless buyback machine: HCA's total stockholders' equity as of December 2025 was negative $6 billion. The company has literally bought back more than 100% of its book equity. This sounds alarming but is actually a sign of financial confidence — you only run negative equity through buybacks if you are certain the business will generate enough cash flow to service the debt indefinitely. Patch Origin 3: $5 Billion Per Year in Organic CapEx — Building for Growth HCA spends approximately $5 billion per year building new hospitals, expanding existing facilities, adding surgery centers, and upgrading technology — all funded with a combination of operating cash flow and debt issuance. This is not wasteful spending. It is the primary source of HCA's long-term revenue and earnings growth. Every new hospital tower, every new freestanding ER, every new surgery center adds incremental revenue. But because these projects take 3–5 years from groundbreaking to full profitability, there is always a lag between the debt incurred (upfront) and the returns generated (over time). The permanent CapEx cycle means HCA is always carrying the debt from projects not yet at full utilization. Why This is Smart, Not Reckless The key to understanding HCA's debt is the difference between leverage level and leverage risk. They are not the same thing. HCA carries ~$45 billion in debt at approximately 3.0–3.5x EBITDA. This sounds large in absolute terms. But consider the characteristics of the business servicing that debt: Cash flow is extraordinarily stable. People do not stop having heart attacks, strokes, or accidents in recessions. Hospital volumes are among the least economically sensitive in the entire economy. HCA's free cash flow has grown consistently for over a decade, never going negative even during COVID (when the government provided relief funding). Over the trailing 12 months to mid-2025, free cash flow totaled $7.3 billion, representing 29.3% growth year-over-year. aol The interest coverage ratio is very comfortable. HCA generates enough operating income to cover its interest expense approximately 5–6x over. Even with $45 billion in debt, the annual interest bill (~$2 billion) is a manageable fraction of ~$14–15 billion in EBITDA. The debt is long-dated and fixed rate. HCA has been an active bond issuer and refinancer, consistently extending maturities and locking in fixed rates. There is no near-term maturity cliff that could create a liquidity crisis. The Negative Equity — Why It's a Feature, Not a Bug HCA's debt-to-equity ratio is negative 8.08x, because its total stockholders' equity of negative $6 billion makes the ratio mathematically nonsensical by conventional metrics. Patch This negative equity is entirely the result of buying back more stock than the company has generated in retained earnings — not operating losses, not write-downs, not bad acquisitions. It is the mechanical result of returning capital to shareholders faster than earnings accumulate. The best parallel is Apple. Apple also has negative or near-zero book equity because it has returned trillions to shareholders through buybacks and dividends. No one considers Apple's balance sheet a warning sign — it reflects a business so confident in its earnings power that it has returned all its equity to owners and borrowed against future earnings. HCA is the hospital sector's version of the same philosophy, executed over a longer time period on a more debt-intensive base. The One Genuine Risk: What Could Go Wrong The debt is not riskless. The scenario where it becomes dangerous is a sustained, simultaneous hit to volumes and pricing: A deep, prolonged recession that reduces elective surgical volumes A severe Medicaid/Medicare cut that compresses margins faster than costs can be reduced A rise in interest rates that makes refinancing expensive In any of these scenarios, HCA's high debt amplifies the downside. A company with no debt and the same earnings decline loses earnings; a company with 3x leverage and the same decline loses earnings and faces rising financial costs. This is why HCA's stock is more volatile than its underlying business fundamentals would suggest — the leverage is a return amplifier in both directions. But management has clearly judged that the probability of a catastrophic, sustained revenue collapse is low enough that maintaining high leverage to fund buybacks and CapEx is the value-maximizing choice for shareholders. Given the track record — decades of consistent cash flow generation, never a near-bankruptcy moment, a stock that has massively outperformed the market over 15 years — it is hard to argue they have been wrong. The Simple Summary Reason for debtAmount (approx.)Intentional?Legacy LBO debt from 2006~$15–20B baselineInherited, rolled forwardShare buybacks funded by new debt~$15B cumulativeDeliberately sustainedOrganic CapEx funded partly by debt~$5B annual cycleStrategic growth investmentTotal~$45BAlmost entirely deliberate HCA's debt is not evidence of a company living beyond its means. It is evidence of a management team that has concluded, correctly so far, that a predictable, cash-generative hospital business can carry substantial leverage while still growing earnings per share aggressively — and that deploying every dollar of free cash flow into buybacks and growth CapEx rather than debt repayment is the highest-return use of capital available to them.
+May 28, 20260why hca has better margins then uhs?There are six distinct reasons why HCA structurally earns better margins than UHS, and they compound on each other. Let me go through each one. 1. Payer Mix — The Single Biggest Driver This is the root cause of almost everything else. Who pays you determines how much you get paid per patient, and the difference between payers is enormous. For HCA's inpatient business, approximately 43–45% of revenue comes from private/commercial insurance, ~40% from Medicare (including Medicare Advantage), and only ~17% from Medicaid, with a small fraction as self-pay. Now compare this to UHS. UHS's acute care segment has a broadly similar mix to HCA, but its behavioral health segment — which represents roughly 43% of total revenue — is structurally dominated by Medicaid. Behavioral health patients are disproportionately lower-income, government-insured individuals. Medicaid pays far less than commercial insurance per patient day, and behavioral health stays are long (averaging 10–14 days inpatient), meaning UHS collects a low daily rate for a long time. The arithmetic is unforgiving. HCA fills beds mostly with commercially insured patients at premium rates. UHS fills beds with a large share of Medicaid behavioral health patients at below-cost rates. Every incremental Medicaid patient dilutes the average revenue per admission and therefore the margin. 2. Service Line Mix — High-Acuity Procedures vs. Long-Stay Behavioral This is the second structural dimension. Not all hospital revenue is created equal — what type of care you provide matters enormously for margins. HCA's acute care hospitals perform high volumes of surgical procedures: cardiac surgery, orthopedics, neurosurgery, oncology. These are high-acuity, short-stay, high-revenue events. A cardiac bypass surgery generates tens of thousands of dollars in revenue in 3–5 days. Commercial insurers pay premium rates for these procedures. HCA's case mix index has been trending higher, with a slight uptick in complex service utilization, and along with favorable payer mix helped lift inpatient revenue per equivalent admission by approximately 6% year-over-year in 2025. UHS's behavioral health division does the opposite — it provides long-stay, lower-acuity care (psychiatric stabilization, addiction treatment) reimbursed on a per-diem basis at rates set by Medicaid. A behavioral health patient staying 12 days at $500/day generates $6,000 in revenue. An orthopedic surgery patient staying 2 days generates $25,000+. The fixed cost of staffing both beds is not proportionally different. This is why behavioral health, despite being a higher-margin business than other hospital services from an operational standpoint, produces lower margins than HCA's acute surgical business in absolute dollar and percentage terms. 3. Scale and Purchasing Power — HCA Is in a Different League HCA benefits from scale advantages that enable centralized purchasing, unified technology platforms, and strong negotiating leverage with commercial payers across its 190+ hospitals in 20 states. The numbers make this concrete. HCA's revenue is ~$75 billion — more than 4x UHS's ~$17 billion. When HCA negotiates with a medical supply company for IV bags, sutures, or imaging equipment, it is the single largest buyer in the country. It extracts pricing that smaller systems literally cannot access. The same applies to: Commercial insurer contract rates — HCA has enough market share in its local markets that insurers must include it in their networks. This gives HCA pricing power most systems lack. Pharmaceutical purchasing — bulk buying through HealthTrust, HCA's group purchasing subsidiary, which also serves third-party hospitals and generates additional fee revenue. Technology platforms — HCA's revenue cycle, EHR, and analytics systems are amortized across 190 hospitals, making the per-hospital cost trivial compared to what a 25-hospital system pays for comparable tools. UHS at $17 billion is a large company by any normal standard, but in negotiations with Humana, UnitedHealth, or Cardinal Health, it is not in the same room as HCA. 4. Revenue Cycle Excellence — HCA Collects More of What It Bills This is less visible but enormously impactful. Revenue cycle is the process of billing insurers, following up on denials, appealing underpayments, and collecting patient balances. The difference between excellent and average revenue cycle management is typically 1–3 percentage points of revenue — which on $75 billion translates to $750M–$2.25 billion. HCA has been aggressively deploying AI across its revenue cycle operations, targeting faster cash conversion, fewer billing denials, optimized staffing, and improved patient throughput. Specifically, AI tools are being used to predict which claims will be denied before submission (so they can be corrected in advance), automate prior authorization workflows, and prioritize collection efforts by probability of recovery. HCA's CFO highlighted "greater success on dispute resolution with payers" as a meaningful contributor to the 6.1% revenue per equivalent admission growth in Q3 2025. In plain English: HCA is getting better at winning fights with insurers over claim denials. Georgetown University UHS's behavioral health revenue cycle is inherently more complex and lower-yield. Medicaid denials in behavioral health are notoriously high, appeal processes are slower, and the per-claim economics don't justify the same investment in automation and dispute resolution that HCA applies to its high-value surgical claims. 5. Labor Cost Structure — Galen Changes the Math Labor is 55–60% of all hospital costs. Even a 1% improvement in labor efficiency as a percentage of revenue moves the margin needle materially. HCA's acquisition of Galen College of Nursing and now the College of Health Care Professions is not just a feel-good workforce story — it is a structural cost advantage. HCA's contract labor expense was "basically flat" year-on-year at 4.2% of total labor costs by late 2025, down from pandemic-era peaks — a direct result of having a proprietary pipeline of nursing graduates. Galen feeds HCA hospitals with new nurses who sign employment agreements as part of their training, reducing dependence on travel nurses who cost 1.5–2x the rate of staff nurses. UHS's behavioral health staffing model has different challenges — it requires high ratios of psychiatric nurses, social workers, and therapists who are scarcer than general acute care nurses. These specialists command premium wages and are harder to pipeline through a nursing college model. UHS relies more heavily on market-rate hiring for this specialized workforce, which keeps labor costs structurally higher relative to revenue generated. 6. Geographic Concentration — Sun Belt Markets vs. UHS's Broader Footprint HCA made a deliberate strategic choice decades ago to concentrate in high-growth Sun Belt markets — Texas, Florida, Tennessee, Nevada, Colorado. These markets share several margin-friendly characteristics: Younger, commercially insured population — younger workers use employer insurance, not Medicaid or Medicare Lower unionization rates — labor costs are structurally lower in right-to-work Sun Belt states Population growth — rising patient volumes without proportional cost increases creates operating leverage Favorable regulatory environment — these states generally impose lighter CON (certificate of need) restrictions, making it easier for HCA to expand capacity when volumes grow UHS's behavioral health hospitals, by contrast, are spread across all 50 states, with significant concentration in markets that reflect the geographic distribution of the Medicaid-dependent population. The Combined Effect — A Margin Waterfall Here is how the gap accumulates across the P&L: DriverHCA advantageUHS disadvantageApproximate margin gapPayer mix43–45% commercialHigh Medicaid/BH exposure~2–3 ptsService acuityHigh-margin surgical mixLong-stay BH per diems~2–3 ptsScale/purchasing$75B buying power$17B buying power~1 ptRevenue cycleAI-enhanced, dispute resolutionBH complexity drag~1 ptLaborGalen pipeline, 4.2% contractBH specialist scarcity~1 ptGeographySun Belt commercial marketsNationwide BH footprint~0.5 ptsTotalHCA operating margin ~13%UHS operating margin ~8.5%~4.5 pts gap The irony is that UHS's behavioral health business — while a margin drag relative to HCA's surgical mix — is actually quite attractive compared to other behavioral health competitors and provides a genuine moat. The problem isn't that behavioral health is a bad business. It's that it structurally cannot produce the same margins as a concentrated, commercial-heavy, high-acuity surgical hospital network. HCA built itself into the most favorable corner of the hospital industry. UHS built itself into a different corner — important, defensible, but inherently lower-margin.
+May 28, 20260why hca has so much debt?HCA's debt story is one of the most interesting capital structure case studies in American corporate history. The debt is not a mistake or a sign of financial distress — it is a deliberate, rational, and sustained strategic choice that has created enormous shareholder wealth. Let me explain why from the ground up. The Three Origins of HCA's Debt HCA's ~$45 billion in debt comes from three distinct, overlapping sources that have compounded over time. Origin 1: The 2006 KKR/Bain LBO — The Original Sin Everything starts here. In 2006, KKR, Bain Capital, Merrill Lynch and the Frist family took HCA private in a $33 billion leveraged buyout — the largest in history at the time — loading the company with approximately $28 billion in debt. sec When HCA re-IPO'd in 2011, it did not pay down that LBO debt — it came back to the public markets already deeply leveraged. The PE firms extracted their returns through the IPO and subsequent share sales, but the debt remained on HCA's balance sheet. This is the permanent baseline of HCA's debt load. Every refinancing since has essentially rolled this debt forward at successively lower interest rates, never meaningfully reducing the principal. This is a critical distinction from, say, CHS — whose debt came from an operationally disastrous acquisition. HCA's foundational debt came from a PE transaction on a healthy business, and the business was strong enough to service it comfortably from day one. Origin 2: Aggressive Share Buybacks Funded by Debt — The Ongoing Machine This is the engine that keeps the debt elevated even as the business generates enormous cash flow, and it is entirely intentional. The logic is a form of financial engineering that works beautifully when executed on a high-quality, stable-cash-flow business: HCA generates ~$7–8 billion in free cash flow per year Rather than using that cash to pay down debt, it borrows more and buys back its own shares Fewer shares outstanding means each remaining share is worth more — EPS grows even if net income is flat The interest rate on HCA's debt (~4–5%) is far cheaper than the implied earnings yield on its stock (~8–10%), making debt-financed buybacks mathematically accretive The scale of this is staggering. HCA bought back 26.7 million shares in 2025 alone and authorized a new $10 billion repurchase program. In 2022, the company bought back $7 billion or 30 million shares in a single year. Since the 2011 IPO, HCA has bought back well over $40 billion of its own stock — nearly the entire current market cap. This buyback activity is financed partly by cash flow and partly by issuing new debt, keeping total debt elevated even as the business grows. sec The result of this relentless buyback machine: HCA's total stockholders' equity as of December 2025 was negative $6 billion. The company has literally bought back more than 100% of its book equity. This sounds alarming but is actually a sign of financial confidence — you only run negative equity through buybacks if you are certain the business will generate enough cash flow to service the debt indefinitely. Patch Origin 3: $5 Billion Per Year in Organic CapEx — Building for Growth HCA spends approximately $5 billion per year building new hospitals, expanding existing facilities, adding surgery centers, and upgrading technology — all funded with a combination of operating cash flow and debt issuance. This is not wasteful spending. It is the primary source of HCA's long-term revenue and earnings growth. Every new hospital tower, every new freestanding ER, every new surgery center adds incremental revenue. But because these projects take 3–5 years from groundbreaking to full profitability, there is always a lag between the debt incurred (upfront) and the returns generated (over time). The permanent CapEx cycle means HCA is always carrying the debt from projects not yet at full utilization. Why This is Smart, Not Reckless The key to understanding HCA's debt is the difference between leverage level and leverage risk. They are not the same thing. HCA carries ~$45 billion in debt at approximately 3.0–3.5x EBITDA. This sounds large in absolute terms. But consider the characteristics of the business servicing that debt: Cash flow is extraordinarily stable. People do not stop having heart attacks, strokes, or accidents in recessions. Hospital volumes are among the least economically sensitive in the entire economy. HCA's free cash flow has grown consistently for over a decade, never going negative even during COVID (when the government provided relief funding). Over the trailing 12 months to mid-2025, free cash flow totaled $7.3 billion, representing 29.3% growth year-over-year. aol The interest coverage ratio is very comfortable. HCA generates enough operating income to cover its interest expense approximately 5–6x over. Even with $45 billion in debt, the annual interest bill (~$2 billion) is a manageable fraction of ~$14–15 billion in EBITDA. The debt is long-dated and fixed rate. HCA has been an active bond issuer and refinancer, consistently extending maturities and locking in fixed rates. There is no near-term maturity cliff that could create a liquidity crisis. The Negative Equity — Why It's a Feature, Not a Bug HCA's debt-to-equity ratio is negative 8.08x, because its total stockholders' equity of negative $6 billion makes the ratio mathematically nonsensical by conventional metrics. Patch This negative equity is entirely the result of buying back more stock than the company has generated in retained earnings — not operating losses, not write-downs, not bad acquisitions. It is the mechanical result of returning capital to shareholders faster than earnings accumulate. The best parallel is Apple. Apple also has negative or near-zero book equity because it has returned trillions to shareholders through buybacks and dividends. No one considers Apple's balance sheet a warning sign — it reflects a business so confident in its earnings power that it has returned all its equity to owners and borrowed against future earnings. HCA is the hospital sector's version of the same philosophy, executed over a longer time period on a more debt-intensive base. The One Genuine Risk: What Could Go Wrong The debt is not riskless. The scenario where it becomes dangerous is a sustained, simultaneous hit to volumes and pricing: A deep, prolonged recession that reduces elective surgical volumes A severe Medicaid/Medicare cut that compresses margins faster than costs can be reduced A rise in interest rates that makes refinancing expensive In any of these scenarios, HCA's high debt amplifies the downside. A company with no debt and the same earnings decline loses earnings; a company with 3x leverage and the same decline loses earnings and faces rising financial costs. This is why HCA's stock is more volatile than its underlying business fundamentals would suggest — the leverage is a return amplifier in both directions. But management has clearly judged that the probability of a catastrophic, sustained revenue collapse is low enough that maintaining high leverage to fund buybacks and CapEx is the value-maximizing choice for shareholders. Given the track record — decades of consistent cash flow generation, never a near-bankruptcy moment, a stock that has massively outperformed the market over 15 years — it is hard to argue they have been wrong. The Simple Summary Reason for debtAmount (approx.)Intentional?Legacy LBO debt from 2006~$15–20B baselineInherited, rolled forwardShare buybacks funded by new debt~$15B cumulativeDeliberately sustainedOrganic CapEx funded partly by debt~$5B annual cycleStrategic growth investmentTotal~$45BAlmost entirely deliberate HCA's debt is not evidence of a company living beyond its means. It is evidence of a management team that has concluded, correctly so far, that a predictable, cash-generative hospital business can carry substantial leverage while still growing earnings per share aggressively — and that deploying every dollar of free cash flow into buybacks and growth CapEx rather than debt repayment is the highest-return use of capital available to them.
+May 28, 20260why hca has better margins then uhs?There are six distinct reasons why HCA structurally earns better margins than UHS, and they compound on each other. Let me go through each one. 1. Payer Mix — The Single Biggest Driver This is the root cause of almost everything else. Who pays you determines how much you get paid per patient, and the difference between payers is enormous. For HCA's inpatient business, approximately 43–45% of revenue comes from private/commercial insurance, ~40% from Medicare (including Medicare Advantage), and only ~17% from Medicaid, with a small fraction as self-pay. Now compare this to UHS. UHS's acute care segment has a broadly similar mix to HCA, but its behavioral health segment — which represents roughly 43% of total revenue — is structurally dominated by Medicaid. Behavioral health patients are disproportionately lower-income, government-insured individuals. Medicaid pays far less than commercial insurance per patient day, and behavioral health stays are long (averaging 10–14 days inpatient), meaning UHS collects a low daily rate for a long time. The arithmetic is unforgiving. HCA fills beds mostly with commercially insured patients at premium rates. UHS fills beds with a large share of Medicaid behavioral health patients at below-cost rates. Every incremental Medicaid patient dilutes the average revenue per admission and therefore the margin. 2. Service Line Mix — High-Acuity Procedures vs. Long-Stay Behavioral This is the second structural dimension. Not all hospital revenue is created equal — what type of care you provide matters enormously for margins. HCA's acute care hospitals perform high volumes of surgical procedures: cardiac surgery, orthopedics, neurosurgery, oncology. These are high-acuity, short-stay, high-revenue events. A cardiac bypass surgery generates tens of thousands of dollars in revenue in 3–5 days. Commercial insurers pay premium rates for these procedures. HCA's case mix index has been trending higher, with a slight uptick in complex service utilization, and along with favorable payer mix helped lift inpatient revenue per equivalent admission by approximately 6% year-over-year in 2025. UHS's behavioral health division does the opposite — it provides long-stay, lower-acuity care (psychiatric stabilization, addiction treatment) reimbursed on a per-diem basis at rates set by Medicaid. A behavioral health patient staying 12 days at $500/day generates $6,000 in revenue. An orthopedic surgery patient staying 2 days generates $25,000+. The fixed cost of staffing both beds is not proportionally different. This is why behavioral health, despite being a higher-margin business than other hospital services from an operational standpoint, produces lower margins than HCA's acute surgical business in absolute dollar and percentage terms. 3. Scale and Purchasing Power — HCA Is in a Different League HCA benefits from scale advantages that enable centralized purchasing, unified technology platforms, and strong negotiating leverage with commercial payers across its 190+ hospitals in 20 states. The numbers make this concrete. HCA's revenue is ~$75 billion — more than 4x UHS's ~$17 billion. When HCA negotiates with a medical supply company for IV bags, sutures, or imaging equipment, it is the single largest buyer in the country. It extracts pricing that smaller systems literally cannot access. The same applies to: Commercial insurer contract rates — HCA has enough market share in its local markets that insurers must include it in their networks. This gives HCA pricing power most systems lack. Pharmaceutical purchasing — bulk buying through HealthTrust, HCA's group purchasing subsidiary, which also serves third-party hospitals and generates additional fee revenue. Technology platforms — HCA's revenue cycle, EHR, and analytics systems are amortized across 190 hospitals, making the per-hospital cost trivial compared to what a 25-hospital system pays for comparable tools. UHS at $17 billion is a large company by any normal standard, but in negotiations with Humana, UnitedHealth, or Cardinal Health, it is not in the same room as HCA. 4. Revenue Cycle Excellence — HCA Collects More of What It Bills This is less visible but enormously impactful. Revenue cycle is the process of billing insurers, following up on denials, appealing underpayments, and collecting patient balances. The difference between excellent and average revenue cycle management is typically 1–3 percentage points of revenue — which on $75 billion translates to $750M–$2.25 billion. HCA has been aggressively deploying AI across its revenue cycle operations, targeting faster cash conversion, fewer billing denials, optimized staffing, and improved patient throughput. Specifically, AI tools are being used to predict which claims will be denied before submission (so they can be corrected in advance), automate prior authorization workflows, and prioritize collection efforts by probability of recovery. HCA's CFO highlighted "greater success on dispute resolution with payers" as a meaningful contributor to the 6.1% revenue per equivalent admission growth in Q3 2025. In plain English: HCA is getting better at winning fights with insurers over claim denials. Georgetown University UHS's behavioral health revenue cycle is inherently more complex and lower-yield. Medicaid denials in behavioral health are notoriously high, appeal processes are slower, and the per-claim economics don't justify the same investment in automation and dispute resolution that HCA applies to its high-value surgical claims. 5. Labor Cost Structure — Galen Changes the Math Labor is 55–60% of all hospital costs. Even a 1% improvement in labor efficiency as a percentage of revenue moves the margin needle materially. HCA's acquisition of Galen College of Nursing and now the College of Health Care Professions is not just a feel-good workforce story — it is a structural cost advantage. HCA's contract labor expense was "basically flat" year-on-year at 4.2% of total labor costs by late 2025, down from pandemic-era peaks — a direct result of having a proprietary pipeline of nursing graduates. Galen feeds HCA hospitals with new nurses who sign employment agreements as part of their training, reducing dependence on travel nurses who cost 1.5–2x the rate of staff nurses. UHS's behavioral health staffing model has different challenges — it requires high ratios of psychiatric nurses, social workers, and therapists who are scarcer than general acute care nurses. These specialists command premium wages and are harder to pipeline through a nursing college model. UHS relies more heavily on market-rate hiring for this specialized workforce, which keeps labor costs structurally higher relative to revenue generated. 6. Geographic Concentration — Sun Belt Markets vs. UHS's Broader Footprint HCA made a deliberate strategic choice decades ago to concentrate in high-growth Sun Belt markets — Texas, Florida, Tennessee, Nevada, Colorado. These markets share several margin-friendly characteristics: Younger, commercially insured population — younger workers use employer insurance, not Medicaid or Medicare Lower unionization rates — labor costs are structurally lower in right-to-work Sun Belt states Population growth — rising patient volumes without proportional cost increases creates operating leverage Favorable regulatory environment — these states generally impose lighter CON (certificate of need) restrictions, making it easier for HCA to expand capacity when volumes grow UHS's behavioral health hospitals, by contrast, are spread across all 50 states, with significant concentration in markets that reflect the geographic distribution of the Medicaid-dependent population. The Combined Effect — A Margin Waterfall Here is how the gap accumulates across the P&L: DriverHCA advantageUHS disadvantageApproximate margin gapPayer mix43–45% commercialHigh Medicaid/BH exposure~2–3 ptsService acuityHigh-margin surgical mixLong-stay BH per diems~2–3 ptsScale/purchasing$75B buying power$17B buying power~1 ptRevenue cycleAI-enhanced, dispute resolutionBH complexity drag~1 ptLaborGalen pipeline, 4.2% contractBH specialist scarcity~1 ptGeographySun Belt commercial marketsNationwide BH footprint~0.5 ptsTotalHCA operating margin ~13%UHS operating margin ~8.5%~4.5 pts gap The irony is that UHS's behavioral health business — while a margin drag relative to HCA's surgical mix — is actually quite attractive compared to other behavioral health competitors and provides a genuine moat. The problem isn't that behavioral health is a bad business. It's that it structurally cannot produce the same margins as a concentrated, commercial-heavy, high-acuity surgical hospital network. HCA built itself into the most favorable corner of the hospital industry. UHS built itself into a different corner — important, defensible, but inherently lower-margin.
+May 28, 20260HCA all the acquisitions and ebitda paidHCA's M&A history is fundamentally different from UHS's. Where UHS makes a few large, transformative deals, HCA runs a high-volume, disciplined, bolt-on machine — smaller deals, right markets, low prices. Here is the full picture. The Foundational Event: The 2006 KKR/Bain LBO Before covering acquisitions HCA made as a public company, you need to understand this transaction because it shaped everything that followed. MetricDetailDeal value$33 billion ($21B cash + $11.7B debt assumed)BuyersKKR, Bain Capital, Merrill Lynch PE, Frist familyHCA's 2006 EBITDA~$3.5BEV/EBITDA paid~9.4xWhat happenedThe largest leveraged buyout in private equity history at the time — KKR, Bain and Merrill Lynch paid $51 per share, a premium of 18% to the pre-rumor price. PitchBook HCA re-IPO'd in 2011, raising $3.8 billion. The PE sponsors made an extraordinary return — the discipline and cost structure instilled during the private years became the foundation of HCA's public market premium. The critical point: HCA emerged from private equity ownership leaner, more focused, and with a sharper capital allocation framework than it entered. HCA's Post-IPO Acquisition Strategy: The Pattern HCA does not make CHS-style $7 billion empire-building bets. Its strategy has been: Acquire hospitals in markets where it already operates — consolidating local market share rather than entering new geographies Buy distressed or non-profit systems at distressed prices — where the seller has no leverage Bolt on adjacent capabilities — nursing education, urgent care, home health — that reduce input costs or expand the care continuum around its hospitals Almost every deal is sub-$2 billion. Many are sub-$500 million. The EBITDA multiples are consistently below where HCA itself trades. The Major Acquisitions 1. Mission Health (North Carolina) — 2019 MetricDetailDeal value$1.5 billionMission revenue~$1.8 billionMission EBITDA~$169 millionEV/EBITDA paid~8.9xEV/Revenue paid0.83xWhat was bought6-hospital nonprofit system, dominant in western North Carolina The 8.86x EBITDA multiple was consistent with where HCA itself traded at the time, but the effective multiple was likely much lower once synergies were factored in. The 0.83x revenue multiple was well below the public peer average of 1.46x at the time — meaning on a revenue basis alone the deal was highly accretive to HCA, which itself traded at 1.78x revenue. VMG Health Mission was a non-profit with a captive regional monopoly — exactly the type of asset HCA prefers. Post-acquisition, HCA applied its revenue cycle, labor management, and contracting advantages to a system that had never had them. The deal has been financially very successful, though it generated significant controversy: the North Carolina attorney general later accused HCA of breaching the terms of the deal by reducing emergency and oncology service levels, receiving more than 500 complaints about the Mission Health facilities. Modern Healthcare 2. Galen College of Nursing — 2020 MetricDetailDeal valueNot publicly disclosed (~$300–400M estimated)What was boughtFor-profit nursing college with 5 campusesStrategic rationaleVertical integration into nurse supply pipelineEBITDA multipleNot disclosed This is a classic HCA lateral move. Rather than paying market rates for travel nurses — which was destroying margins across the sector during COVID — HCA bought its own nursing school. HCA paid $400 million for a majority 80% stake in Galen, creating what management called "the largest academic practice partnership in all of US healthcare." Galen graduates are funnelled directly into HCA hospitals, reducing dependence on expensive agency staffing. This is textbook vertical integration — solving an input cost problem through ownership rather than market purchasing. Hcahealthcare 3. Brookdale Home Health JV — 2021 MetricDetailDeal value$400 million for 80% stakeRevenue (at ~1.1x 2019 sales)~$380M annualizedEV/Revenue paid~1.1xWhat was bought80% of Brookdale's home health and hospice agenciesOutcomePartial exit — sold 47 locations to LHC Group later in 2021 HCA paid approximately 1.1x Brookdale's 2019 sales, below what analysts considered fair value for home health assets at the time, reflecting Brookdale's weakened negotiating position. HCA then rationalized the portfolio almost immediately, selling 47 non-strategic locations to LHC Group and retaining only those home health agencies adjacent to its existing hospital markets. A neat example of buying a portfolio, keeping what fits, and flipping the rest — essentially getting the strategic assets at a discount. Home Health Care News 4. MD Now Urgent Care — 2022 MetricDetailDeal valueNot publicly disclosedWhat was bought59 urgent care centers across FloridaStrategic rationaleCapture lower-acuity patients in Florida markets, funnel to HCA hospitalsEBITDA multipleNot disclosed Florida is HCA's single largest market. MD Now gave HCA a network of outpatient touchpoints to capture patients before they ever reach a competitor's ER — a classic market density play. Urgent care multiples in 2022 were approximately 10–14x EBITDA, but HCA likely paid at the lower end given the Florida-specific nature of the portfolio. 5. Catholic Medical Center (New Hampshire) — 2025 MetricDetailDeal value$110 millionCMC beds330-bed acute care hospitalCMC financialsProjected $41.5M operating loss in 2024; ~$160M in debtEV/EBITDA paidNegative EBITDA at acquisitionCommitted capital investmentAdditional $200M over 10 years CMC was on the brink of bankruptcy when HCA acquired it, projecting a $41.5 million loss, with credit agencies downgrading it and insufficient cash to replace a crumbling power plant that "would render the hospital wholly inoperable" if it failed. Yahoo Finance HCA paid $110M for a distressed asset that regulators needed saved — giving HCA enormous leverage in negotiations. The real cost is the $200M capital commitment, making total outlay ~$310M for a 330-bed hospital in a market (Manchester, NH) where HCA already operated three other facilities. On a per-bed basis ($940K/bed), this is well below greenfield construction costs of $1.5–2M per bed. Once HCA applies its operational playbook to a turnaround, the returns on distressed acquisitions like this are typically very high. 6. College of Health Care Professions — 2026 (recent) MetricDetailDeal valueNot disclosedWhat was boughtTexas-based for-profit healthcare vocational collegeStrategic rationaleExpanding Galen playbook — building out allied health workforce pipeline (medical assistants, etc.) HCA and CHCP had already been collaborating on a 12-week Medical Assistant training program for HCA's urgent care centers in Texas before the acquisition. This follows the Galen template exactly — first partner, then acquire once the strategic fit is proven. Investing.com HCA's Organic Capital Deployment: The Bigger Story Here is the insight most acquisition analyses miss about HCA: its most important capital allocation is not acquisitions — it's organic reinvestment and buybacks. HCA spends approximately $5 billion per year in capital expenditures on its existing hospital network — building new towers, adding beds, upgrading clinical programs, expanding surgery centers. This organic reinvestment is where HCA has generated its extraordinary ROIC of 17–18%, far above what acquisitions alone could produce. And when it isn't reinvesting, it is buying back its own stock aggressively. In 2022 alone, HCA bought back $7 billion or 30 million shares. Since 2019, the share count has declined from ~350M shares to ~260M — a 26% reduction — which mechanically drives EPS growth even when revenue growth is modest. Nhsforsale Summary: The HCA Acquisition Philosophy vs. Peers DimensionHCAUHSCHS (cautionary tale)Deal size preferenceSmall-medium bolts-onOccasional large transformativeOne catastrophic mega-dealPrice disciplineVery high (buys distressed)Good (PSI, Ascend)Poor (HMA at peak)Typical EV/EBITDA8–10x, often less for distressed8–10x for proven assets8.7x but wrong assetsPrimary growth engineOrganic CapEx + buybacksBehavioral health organicDivestitures (undoing past M&A)Post-close track recordStrong (Mission synergies)Mixed (Cedar Hill execution)Consistently disappointing The HCA pattern reveals something important about what separates great capital allocators from average ones: it's not the multiple paid, it's the quality of the asset and the ability to improve it post-close. HCA consistently buys non-profits with poor operational discipline and applies its scale advantages — revenue cycle, labor, contracting — to extract synergies that justify the price. The multiples paid (8–10x) look similar to peers, but the returns generated are materially higher because of superior post-acquisition execution.